Silver Spring, MD, United States of America

Heather Greenstone

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1997-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Heather Greenstone

Introduction

Heather Greenstone is a prominent inventor based in Silver Spring, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of papillomavirus-like particles. With a total of 4 patents to her name, her work has implications for vaccine development and disease prevention.

Latest Patents

Among her latest patents is the invention of chimeric papillomavirus-like particles. This invention provides a papillomavirus-like particle characterized by conformational epitopes, which include a papillomavirus L1 product and a papillomavirus L2 fusion product. Additionally, it encompasses related synthetic DNA molecules, host cells, methods, and vaccines. This innovative approach has the potential to enhance vaccine efficacy and broaden the scope of immunization strategies.

Career Highlights

Throughout her career, Heather has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these institutions has allowed her to contribute to significant advancements in public health and medical research.

Collaborations

Heather has collaborated with notable figures in her field, including Douglas R. Lowy and John T. Schiller. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas, further enhancing the impact of her work.

Conclusion

Heather Greenstone's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence vaccine development and public health initiatives, showcasing the importance of innovation in addressing global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…